×
About 2,268 results

ALLMedicine™ Erythema Multiforme Center

Research & Reviews  334 results

Toxic Epidermal Necrolysis (TEN)
http://emedicine.medscape.com/article/229698-overview

Jun 7th, 2022 - Background Toxic epidermal necrolysis (TEN) is a potentially life-threatening dermatologic disorder characterized by widespread erythema, necrosis, and bullous detachment of the epidermis and mucous membranes, resulting in exfoliation and possible...

Toxic Epidermal Necrolysis (TEN)
https://emedicine.medscape.com/article/229698-overview

Jun 7th, 2022 - Background Toxic epidermal necrolysis (TEN) is a potentially life-threatening dermatologic disorder characterized by widespread erythema, necrosis, and bullous detachment of the epidermis and mucous membranes, resulting in exfoliation and possible...

Toxic Epidermal Necrolysis (TEN)
https://emedicine.medscape.com/article/229698-print

Jun 7th, 2022 - Background Toxic epidermal necrolysis (TEN) is a potentially life-threatening dermatologic disorder characterized by widespread erythema, necrosis, and bullous detachment of the epidermis and mucous membranes, resulting in exfoliation and possible...

Erythema multiforme associated with anti-plakin antibodies: a multicentric retrospectiv...
https://doi.org/10.1111/jdv.18259
Journal of the European Academy of Dermatology and Venere... Weill A, Descamps V et. al.

May 25th, 2022 - Erythema multiforme (EM) is a muco-cutaneous inflammatory disease mainly triggered by herpes simplex virus (HSV) recurrences. Association of EM and circulating auto-antibodies against plakins (anti-PLK-Abs [EM-PLK+]) has been reported. However, li...

Erythema multiforme in a young adult following COVID-19 infection and vaccination in Ta...
https://doi.org/10.1136/bcr-2021-247168
BMJ Case Reports; Manji KP, Mwaniki G et. al.

May 24th, 2022 - We report the case of a young female adult in her early 20s, who had COVID-19 infection for 8 weeks and COVID-19 vaccination 4 weeks prior to presentation with an extensive rash associated with erythema multiforme, resembling varicella zoster on i...

see more →

Drugs  490 results see all →

Clinicaltrials.gov  3 results

Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
https://clinicaltrials.gov/ct2/show/NCT03659227

May 3rd, 2022 - Intro: Dermatology department of Henri Mondor Hospital (Creteil, France), is a reference center for toxic bullous diseases and severe cutaneous drug reactions (Stevens-Johnson syndrome (SJS), Lyell syndrome (toxic epidermal necrolysis (TEN)), gene...

A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris
https://clinicaltrials.gov/ct2/show/NCT04940767

Mar 23rd, 2022 - Acne vulgaris is a common disease of both males and females, usually manifesting initially during adolescence. The primary pathologic events are initiated in the pilosebaceous units, especially of sebaceous-gland-bearing areas of the face, chest, ...

Refractory Meibomian Gland Dysfunction and Plasma Jet
https://clinicaltrials.gov/ct2/show/NCT04608942

Oct 30th, 2020 - INTRODUCTION Dry eye disease (DED) is one of the most prevalent conditions at an ophthalmology office that may reach 15 to 40% of prevalence in the population. It is didactically classified as two forms that exist as a continuum: aqueous deficient...

see more →

News  79 results

Neoadjuvant Enfortumab Vedotin Demonstrates Encouraging Activity in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
https://www.onclive.com/view/neoadjuvant-enfortumab-vedotin-demonstrates-encouraging-activity-in-cisplatin-ineligible-muscle-invasive-bladder-cancer

Mar 18th, 2022 - Enfortumab vedotin (Padcev) produced promising antitumor activity when used as neoadjuvant treatment in patients with muscle invasive bladder cancer (MIBC) who were not eligible for cisplatin, according to preliminary findings from cohort H of the...

A 34-year-old male presented with 10 days of a pruritic rash
https://www.mdedge.com/dermatology/article/251815/medical-dermatology/34-year-old-male-presented-10-days-pruritic-rash
Jessica Pham, BA, Brooke Resh Sateesh, MD

Feb 15th, 2022 - Erythema multiforme (EM) is a hypersensitivity reaction commonly caused by herpes simplex virus (HSV) infection. Less frequently observable infectious agents associated with EM are Mycoplasma pneumoniae, Histoplasma capsulatum, and parapoxvirus (o.

Ulcerated and Verrucous Plaque on the Chest
https://www.mdedge.com/dermatology/article/244365/infectious-diseases/ulcerated-and-verrucous-plaque-chest
Mahdieh Fazel Jedlowski, MD, PharmD, Patrick Michael Jedlowski, MD

Aug 17th, 2021 - The Diagnosis: Disseminated Coccidioidomycosis A6-mm punch biopsy was performed at the periphery of the ulcerated cutaneous lesion on the chest revealing extensive spherules. Serum antibody immunodiffusion for histoplasmosis and blastomycoses both.

EU Looking Into New Possible Side Effects of MRNA COVID-19 Shots
https://www.medscape.com/viewarticle/956419

Aug 12th, 2021 - (Reuters) - Three new conditions reported by a small number of people after vaccination with COVID-19 shots from Pfizer and Moderna are being studied to assess if they may be possible side-effects, Europe's drugs regulator said on Wednesday. Eryth...

Targetoid eruption
https://www.mdedge.com/familymedicine/article/242633/dermatology/targetoid-eruption
MDedge Family Medicine;

Jul 15th, 2021 - The clinical features of targetoid lesions occurring soon after herpes simplex virus (HSV) infection points to a diagnosis of erythema multiforme (EM), which was confirmed by punch biopsy. The differential diagnosis for targetoid small lesions inc.

see more →

Patient Education  1 results see all →